Being successful at prevention: Making it easy to do the right thing

Archives of Internal Medicine

Volumn 171, Issue 21, 2011, Pages 1917-1919

  Steinhubl, Steven R ^a,b   Bloom Jr , Frederick J ^b   Darer, Jonathan ^b  

^a Department of Cardiology ^*  (United States)

^b GEISINGER HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COST OF ILLNESS; DECISION SUPPORT SYSTEM; DISEASE COURSE; E-MAIL; ELECTRONIC MEDICAL RECORD; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INTERNET PROTOCOL; MEDICAL EDUCATION; MEDICAL TECHNOLOGY; MOTIVATION; NOTE; PATIENT EDUCATION; PRIORITY JOURNAL; REINFORCEMENT; SECONDARY PREVENTION; UNITED STATES;

EID: 82455186090     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.532     Document Type: Note

References (11)

1. Ni M. The Yellow Emperor's Classic of Medicine: A New Translation of the Neijing Suwen With Commentary. Boston, MA: Shambhala Publications Inc; 1995.
2. Heidenreich PA, Trogdon JG, Khavjou OA, et al. American Heart Association Advocacy Coordinating Committee; Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Cardiopulmonary; Critical Care; Perioperative and Resuscitation; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease; Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933-944.
3. Briffa TG, Hobbs MS, Tonkin A, et al. Population trends of recurrent coronary heart disease event rates remain high. Circ Cardiovasc Qual Outcomes. 2011;4(1):107-113.
4. Lonn E, Bosch J, Teo KK, Pais P, Xavier D, Yusuf S. The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions. Circulation. 2010;122(20):2078-2088.
5. Maddox TM, Ho PM, Roe M, Dai D, Tsai TT, Rumsfeld JS. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry. Circ Cardiovasc Qual Outcomes. 2010;3(6):632-641.
6. Newby LK, LaPointe NM, Chen AY, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006;113(2):203-212.
7. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297(2):177-186. (Pubitemid 46089734)
8. Levine DA, Funkhouser EM, Houston TK, et al. Improving care after myocardial infarction using a 2-year Internet-delivered intervention: the Department of Veterans Affairs Myocardial Infarction-Plus cluster randomized trial. Arch Intern Med. 2011;171(21):1910-1917.
9. Weber V, Bloom F, Pierdon S, Wood C. Employing the electronic health record to improve diabetes care: a multifaceted intervention in an integrated delivery system. J Gen Intern Med. 2008;23(4):379-382. (Pubitemid 351464865)
10. Schedlbauer A, Davies P, Fahey T. Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev. 2010;(3):CD004371.
11. Pittman DG, Chen W, Bowlin SJ, Foody JM. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations. Am J Cardiol. 2011;107(11):1662-1666.